While not explicitly oncolytic viruses, presumably the efficacy of these approaches engages some element of antigen release by viral lytic activity and the additional innate sensing pathways activated by viral infection of cancer cells, in combination with myeloid cell activation by CD40 stimulation. This evidence concerns the gene CD40 and cancer.